CIK 0001510964 · Non-accelerated filer<br>Smaller reporting company
CV Sciences, Inc.
Sign in to watch- Ticker
- CVSI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800944970
- Phone
- 866-290-2157
- Business address
- 9530 PADGETT STREET, SUITE 107, SAN DIEGO, CA, 92126
- Former names
- CannaVEST Corp., Foreclosure Solutions, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-21 | McCorkle William Director | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2022-08-12 | Corroon James Michael Jr. Director | Grant or award · Employee Stock Option (right to buy) | +500,000 | $0.03 | $16K | 500,000 |
| 2022-03-30 | Grasser Joerg CFO | Returned to the company · Employee Stock Option (right to buy) | −750,000 | 0 | ||
| 2022-03-30 | Grasser Joerg CFO | Returned to the company · Employee Stock Option (right to buy) | −750,000 | 0 | ||
| 2022-03-30 | Grasser Joerg CFO | Returned to the company · Employee Stock Option (right to buy) | −250,000 | 0 | ||
| 2022-03-30 | Grasser Joerg CFO | Returned to the company · Employee Stock Option (right to buy) | −250,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −1,500,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −1,500,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −500,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −500,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −100,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −200,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −100,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −600,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −1,000,000 | 0 | ||
| 2022-03-30 | Dowling Joseph D CEO | Returned to the company · Employee Stock Option (right to buy) | −1,000,000 | 0 | ||
| 2021-06-02 | BLAKE PAUL Director | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2021-06-02 | Altman Elizabeth Ann Director | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2021-06-02 | MAROON JOSEPH C MD Director | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 | ||
| 2021-06-02 | GRAHAM TERRI F Director | Grant or award · Stock Option (right to buy) | +275,000 | 275,000 |
Page 2 of 9 · 163 trades